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Objective: Formation of encapsulating, avascular ﬁbrous tissue is deemed to decrease
implant’s biocompatibility and versatility. We investigated whether plasma-mediated
collagen coating possesses the ability to enhance neovascularization in the vicinity of
silicone implants. Methods: Plasma-treated collagen-I–coated silicone samples were
placed into the dorsal skinfold chambers of female balb/c mice (n = 10). Conven-
tional silicone served as control (n = 10). Intravital microscopy was performed within
implant’s surrounding tissue on days 1, 5, and 10. Functional vessel density, intervas-
cular distance, vessel diameter, microvascular permeability, red blood cell velocity, and
leukocyte-endotheliuminteractionweredetermined.Results:Enhancedangiogenesisin
the tissue surrounding plasma-pretreated collagen-coated implants was noted. Signiﬁ-
cantincreaseoffunctionalvesseldensityduetovascularnewdevelopmentwasobserved
(t test, P < .05). Analyses of microvascular permeability and red blood cell velocity
displayed stable perfusion of the vascular network neighboring the surface-modiﬁed
implants. Conclusion: Intensiﬁed vascularity due to induced angiogenesis and neovas-
cularization in the tissue surrounding plasma-collagen–coated samples were observed.
These results indicate that plasma-mediated collagen coating might be a promising
technology in order to improve the biocompatibility and versatility of silicone implants.
Silicone implants are often encapsulated by avascular ﬁbrous tissue isolating them
from the adjacent tissue. The ﬁbrous capsule around the silicone implants, however, can
lead to capsular contracture, one of the main complications after breast reconstruction and
augmentation,whichcancausepainfulindurationsandimplantextrusionmakingasurgical
revision inevitable.1-3
The pathogenesis of ﬁbrous encapsulation of implanted biomaterials is still uncertain.
Several factors, such as ﬁller material, implant placement, surface texture, and bacterial
infection, have been accused to cause this pathological condition.4-6 Chemical, physical,
and morphological characteristics of biomaterial surfaces are considered to play essential
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role in modulating cellular response at the tissue-/material interface.7,8 In view of this
fact, great effort has been made to modify the interface of silicone implants by altering
the surface texture to reduce the incidence of early capsular formation and contracture.
However, previous studies indicate that alteration of the surface texture alone did not lead
to a signiﬁcant improvement of implants’ biocompatibility.9-11
In contrast, bioactive surface coatings have emerged as a promising approach to im-
prove the biocompatibility of such implants. Especially, collagen coating has been likened
to an enhanced cell afﬁnity to biomaterials. Therefore, this extracellular matrix protein
has often been used in the ﬁeld of biomedical and tissue engineering. Collagen, due to
its cell-binding domain containing the amino acid’s sequence arginine-glycine-asparagine,
interacts with the cellular membrane via integrin receptors, and thereby inﬂuences cell
growth, migration, differentiation, and adhesion.12,13 Coating of biomaterial surfaces with
extracellular matrix components such as collagen has been noted to increase the vascular-
ization of artiﬁcial scaffolds as well as the surrounding tissue of metallic implants.14,15
The lack of sufﬁcient blood supply of the peri-implant tissue was recognized to limit
the functionality of implants, especially, of those implants designed to release or detect
molecules, such as drug delivery or sensing devices.16,17
Hence, an improved tissue-implant interaction leading to an enhanced formation of
new blood vessels around the implant and decreasing the risk of capsule formation and
subsequent capsular contraction is desirable. Biomimetic coatings that can be applied to
implant surface to promote vascularization may thereby reduce the foreign body reaction
and disrupt ﬁbrous encapsulation.
However, an effective coating method of silicon surfaces that stimulates angiogenesis
of the peri-implant tissue is currently not available.
Silicone used in plastic and reconstructive surgery is heat-sensitive and hydrophobic.
Becauseofthesecharacteristics,thecoatingofsilicone,forexample,withcollagenremains
difﬁcult.Coldlow-pressuregasplasmamaypossiblycircumventthisobstacle.Coldplasma
is a partially ionized low-pressure gas comprising ions, electrons, and ultraviolet photons,
as well as reactive neutral species with sufﬁcient energy to break covalent bonds on the
material surface.18 Plasma treatment is a dry, cold (< 40◦C), nontoxic and fast process,
which makes it especially suitable for the treatment of vulnarable materials. Gas plasma
does not cause structural damage of the implant but only interferes with the superﬁcial
layer of the material. The activation of the material surface via plasma treatment enhances
the protein adhesion on the material; therefore, low-pressure plasma has the potential to
provide bioactive protein coatings on implant surfaces.19,20
The aim of this study was to evaluate the biological response to plasma-mediated
collagen-I–coated silicone implant material in vivo with special interest regarding the
angiogenesis and neovascularization of the peri-implant tissue.
MATERIALS AND METHODS
Implant material
Standard texturized silicone implants for breast augmentation (Polytech Silimed, Deis-
senhofen, Germany) were used in both groups. The discoid implants had standardized
dimensions (diameter, 2 mm; thickness, 300 μm).
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The groups were as follows:
Group I: plasma pretreated and collagen-I–coated silcone samples (n = 10).
Group II: regular silicone implant material (non–plasma treated and non–collagen
coated) served as control (n = 10).
Plasma pretreatment
A double inductively coupled plasma reactor (Institute for Plasma Technology, Ruhr Uni-
versity Bochum, Germany) was used for coating experiments. The plasma was ignited and
heated by an RF source at 13.65 MHz with a forward power of 1000 W. A gas mixture of
argon (100 sccm) and oxygen (5 sccm) with a pressure of 10 Pa was used in this study.
Each probe was treated for a duration of 5 minutes.
Collagen-coating procedure
Collagen type I from rat tail 4 mg/mL in 20 mM acetic acid (BD Biosciences, Bedford,
Mass)wasdiluted1:8withphosphatebufferedsalinetoaﬁnalconcentrationof0.5mg/mL.
After plasma treatment, 10 implants were incubated with 500 μL/cm2 for 24 hours at 4◦C
under sterile conditions. After 24 hours, the supernatant was discarded, and the probes
were incubated for another 48 hours at 37◦C. After drying, the implants were rinsed with
phosphate-buffered saline and destilled water several times to wash off the nonadherent
protein.
Animals
The experiments were conducted in accordance with the European guidelines for the care
anduseoflaboratoryanimalsandGermanlawfortheprotectionofanimals.Theexperiment
comprised 20 female balb/c mice (Charles River, Sulzfeld, Germany) weighing from 18
to 22 g. The animals were caged individually. Tap water and standard laboratory food for
mice (Sniff, Soest, Germany) were provided.
Dorsal skinfold chamber
Using an operation stereomicroscope, 2 titanium chamber frames were implanted to sand-
wich the stretched skinfold of animal’s back. One layer of skin was completely excised in
a circular fashion, and the remaining striated skin muscle layer of the opposite side was
covered with a coverslip.21
Forty-eight hours after the surgery, the implants were placed in direct contact to the
perfused striated skin muscle in the center of the chamber. The chamber was then closed
using a new sterile coverslip.
Intravital ﬂuorescence microscopy
Microscopic observation was performed on days 1, 5, and 10 postimplantation. Standard
intravitalmicroscopywasusedformicrocirculatoryobservationsafterintravenousinjection
of 50 μL of 1% FITC (ﬂuorescein-isothiocyanate)-labeled Dextran (MW 150.000) and
50 μL of 0.5% Rhodamin G6 (both: Sigma Chemicals, Deisenhofen, Germany) via tail
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vein. An intravital microscope with a 40-fold water immersion objective (Zeiss, Axiotech
Vario 100 HD, Achroplan 20 × 0.5 W, Zeiss, Oberkochen, Germany) was used to examine
the microvasculature.
Three different regions of interest were deﬁned within the tissue immediately sur-
rounding the implants and recorded and outlined using the Axiovision 3.1 system (Carl-
Zeiss-VisionGmbH,Oberkochen,Germany)forexactrelocation.Attheendoftheprotocol,
the implants were harvested for histological examination.
Data acquisition
Analysis of the intravital video imaging was performed by using the computer program
CapImage (Dr Zeintl, Heidelberg, Germany). Functional vessel density (FVD in cm/cm2),
intervascular distance (μm), vessel diameter (VD in μm), microvascular permeability
(Ie/Ii), red blood cell velocity (mm/s), and leukocyte-endothelium interaction expressed by
the number of adherent leukocytes (n/mm2) were measured for the assessment of microcir-
culatory changes.22 Statistical analysis was performed using t test (P <. 0 5w a sr e g a r d e d
as statistically signiﬁcant) using SigmaStat (SPSS Inc, Version 2.03, Chicago, Ill).
RESULTS
Macroscopically a restricted zone of edema formation around the implants could be seen
from day 5 (Figs 1a and 1b). On day 10, the tissue surrounding the plasma-collagen–coated
silicone implants showed a noticeable hyperemic hem, which was prominent in treated
group compared with controls (Figs 1c and 1d).
Figure 1. Theimagesshowanedemawall(arrows)thatdevelopedaround
untreated (a) and plasma-pretreated collagen-coated (b) silicone implants
on day 5 postimplantation (Implant diameter = 2 mm). On day 10 postim-
plantation, the muscle tissue surrounding the coated implants (d)s h o wa
prominenthyperemichem(triangle).Thehyperemiaoftheadjacenttissue
of untreated implant is less intensive (c).
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Figure 1. (Continued)
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Figure 2. Theintravitalﬂuorescenceimagesoftheborderzoneof
plasma-collagen–coated silicone implants show normal arranged
capillaries of the striated skin muscle on day 1 postimplanta-
tion (a). Dilated and perfused capillaries bearing vessel sprouts
(triangle) surrounded by a pronounced paravascular edema for-
mation due to extravasation of plasma marker FITC (ﬂuorescein-
isothiocyanate)-Dextran were detected on day 5 (b). Increased
vascular density due to vessel new development and remodeling
of the vascular network were noted on day 10 (c) (magniﬁcation:
350-fold).
The intravital microscopy of the peri-implant tissue reinforced this observation, where
anincreaseinvesseldiameterofperfusedmicrovessels,newvesseldevelopment,andraised
vascular density in the treated implant group was noted on days 5 and 10, respectively
(Figs 2a–2c). On day 5, the FVD in the border zone of collagen-coated plasma-treated
implants was 271 ± 9.8 cm/cm2 and around 291 ± 8.5 cm/cm2 on day 10 on average
(mean ± SEM). In comparison, the FVD in the border zone of the untreated implants
averaged around 241 ± 10.4 cm/cm2 on day 5 and 253 ± 10 cm/cm2 o nd a y1 0( F i g3 a ) .
The differences among the groups reached statistical signiﬁcance. In addition, the vessel
diameters displayed signiﬁcantly increased values for the treatment group on days 5 and 10
compared with controls (Fig 3b).
The examination of the intervascular distance demonstrated a progressive and signiﬁ-
cant reduction from day 1 to day 10 in both groups (Fig 3c). The analyses of red blood cell
velocity and microvascular permeability revealed resolute perfusion and stability of newly
developed blood-vessel network around the collagen-coated plasma-treated implants (Figs
3d and 3e). The microvascular permeability was found to be signiﬁcantly increased on day
5 in treated implant group as compared with controls.
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Figure 2. (Continued)
The examination of the leukocyte-endothelium interaction showed that the quantity of
leukocytes adhering to vessel walls decreased over the observation period (Figs 4a and 4b).
Signiﬁcant differences between the groups were found on day 10 (Fig 3f).
The histological examination of the samples showed few inﬂammatory cells pen-
etrating into the surrounding skin muscle tissue in the treated implant group (Fig 5a).
On the contrary, a noticeable accumulation of inﬂammatory cells, mainly leukocytes and
macrophages, as well as few foreign body giant cells, was detected at the implant-tissue
interface in the untreated implant group. In addition, the ﬁbrous deposition was found more
pronounced in untreated group (Fig 5b) whereas the muscle and the ﬁbrous layer in treated
implants displayed a higher vascular content (Fig 5c).
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Figure 3. The graphs display the quantiﬁcation of standard microcircula-
tory parameters. (a) Increasing functional (perfused) vessel density (FVD)
wasnotedwithintheborderzonesofuntreatedandcoatedimplantsthrough-
out the experiment. The differences among the groups reached statistical
signiﬁcance on days 5 and 10. (b) The assessment of vessel diameter (VD)
demonstratedsigniﬁcantlyincreasedvalues forthetreatmentgroupondays
5 and 10. (c) The examination of the intervascular distance demonstrated a
progressive and signiﬁcant reduction from day 1 to day 10 in both groups.
(d)The analyses of red blood cell velocity revealed a stableperfusion of the
blood-vessel network in implant adjacent tissue. (e) The microvascular per-
meabilitywasfoundtobesigniﬁcantlyincreasedonday5intreatedimplant
group as compared with controls. ( f ) The examination of the leukocyte-
endothelium interaction showed that the quantity of leukocytes adhering to
vesselwallsdecreasedfromday1today10.Signiﬁcantdifferencesbetween
the groups were found on day 10 (t test, P < .05).
DISCUSSION
An improved surface hydrophilicity due to gas plasma treatment was demonstrated for var-
ious synthetic implant materials, for example, PET, PTFE, and poly(lactide-co-glycolide),
whereby enhanced attachment and proliferation of human skin–derived ﬁbroblasts, the
growth of human endothelial cells, and platelets were found. An enhanced cell adhesion on
poly(D,L-lactide) was also shown for the combination of gas plasma surface pretreatment
with collagen coating.23-26
One of the ﬁrst attempts to increase the biocompatibility of silicone implant materials
by surface coating with collagen was made by Ksander et al. This collagen coating led
to a signiﬁcantly reduced capsule formation. However, the collagen was cross-linked with
formaldehyde and glutaraldehyde. Due to cytotoxic and carcinogenic properties of these
chemical additives, this surface treatment turned out to be unsuitable for in vivo use.27,28
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Figure 3. (Continued)
Increased collagen adsorption and improved collagen adhesion to plasma-treated im-
plantsurfaceswaslatershownbyG¨ olanderetal,29 whoprovedthattheextentofsurface-free
energy is a decisive factor in terms of the protein-binding capacity of an implant surface.
B a i e re ta l 30 described that a high level of surface-free energy improves the adsorption
of hydrophilic proteins such as collagen. The plasma-induced enhanced hydrophilicity of
silicone led to optimization of collagen binding on implants surface.
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Figure 3. (Continued)
Previous in vitro cell experiments revealed that cell adhesion and cell viability of
murine ﬁbroblasts is signiﬁcantly enhanced on plasma-activated and collagen-coated sil-
icone implants.26 Besides, it was observed that the surface modiﬁcation by gas plasma
inﬂuenced the progress of new vessel formation and promoted vascular inﬁltration in poly-
mer scaffolds.21
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Figure 3. (Continued)
Figure 4. The intravital ﬂuorescence images display the
leukocyte-endothelium interaction on day 1 (a) and day 10
(b) within border zone of plasma-collagen–coated silicone
implants. A quantitative reduction of leukocytes adhering to
vessel walls of a postcapillary venule (arrows) was observed
throughout the experiment (magniﬁcation: 350-fold).
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Figure 4. (Continued)
In the current study, a signiﬁcant increase of neovascularization within tissue adjacent
to the silicone implants when pretreated with cold low-pressure plasma and coated with
collagen was detected. The peri-implant tissue of treated silicone material showed an
intensiﬁed microvascular growth. During the observation period, an increased perfusion of
the new-developed vascular network around collagen-coated plasma-treated implants was
noted as quantiﬁed by standard microcirculatory parameters as functional vessel density,
vessel diameter, and ﬂow velocity. The enhanced vascular density of the peri-implant tissue
inplasma-treatedcollagen-coatedgroupasassessedbyintravitalmicroscopywasassociated
with a higher vascular content within the muscle layer at the implant-/tissue interface in
histology.
In contrast to the treated silicone implants, the implant-/tissue interface in the control
group revealed histologically a pronounced inﬁltration of inﬂammatory cells especially
as leukocytes. Although the presence of macrophages at the implant-/tissue interface was
noted in both groups, the macrophages appeared to accumulate to a higher degree in the
untreatedimplantgroup.Onthecontrary,theintravitalquantiﬁcationofleukocytesadherent
to vessel walls of postcapillary venules, however, did not reﬂect the histological ﬁndings.
Thenumberofstickingleukocyteswasnotelevatedbutratherdecreasedovertheincubation
period of 10 days in both groups. An intensive accumulation of adherent leukocytes, which
could have explained the histological ﬁnding of a high rate of penetration into the muscle
and capsule tissue by inﬂammatory cells were not found during intravital microscopy.
The biomaterial surface may activate inﬂammatory cells and modulate their cytokine
and chemokine release. Macrophage-derived cytokines are known to activate leukocytes,
which increase the rate of monocyte adhesion and fusion. Especially macrophages guide
the foreign body response thus leading to a ﬁbrous encapsulation of the implant.31-33
Jones et al34 demonstrated that material surface has impact on macrophage-derived
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secretion of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs). It
was found that macrophages while activated by material surface produce a greater quantity
of angiogenesis-associated factors such as MMP-9, TIMP-1, and TIMP-2. Besides these
ﬁndings,thereareindicationsthattheelevatedsystemicconcentrationoftissueinhibitorsof
metalloproteinases is associated with the pathogenesis of ﬁbrosis after breast augmentation
with silicone implants. Ulrich et al35 found that the balance between MMPs and TIMPs
is disturbed in patients with capsule contracture thus causing alteration in synthesis and
deposition of collagen surrounding implants.36
In the current study, the extravasation of the plasma marker FITC-Dextran, however,
showed that the edema formation in perivascular space was only a transient phenomenon
in collagen-coated plasma-treated group. The increased microvascular permeability found
on day 5 postimplantation as compared with control was not associated with a prolonged
loss of vascular integrity.
Figure 5. (a) The image shows the cross-section of a skin tissue sample (hematoxylin
and eosin staining) that was exposed to plasma-treated collagen-coated silicone im-
plant.(E=epidermis,D=dermis,S=subcutis,M=striatedskinmuscle,C=capsule).
Leukocytes (arrows) penetrate the skin muscle layer (M) directed to the capsular tissue
(C). Macrophages (MaPh) are evident at the capsule-muscle interface (magniﬁcation:
100-fold).(b)Anextensiveﬁbrousdepositionwithintheimplantcapsuleandenhanced
inﬁltrationofthecapsulartissuebyleukocyteswerefoundintheuntreatedgroup(mag-
niﬁcation: 200-fold). (c) The muscle and the ﬁbrous capsular layer of treated implants
show a high vascular inﬁltration (blood vessels are marked by triangles). Macrophages
(MaPh)andaforeign-bodygiant-cell(FBGC)aredetectedwithinthemusclelayer.The
inﬂammatory cells are directed towards implant’s capsule (magniﬁcation: 200-fold).
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Figure 5. (Continued)
The reduction of vascular integrity leading to increased permeability is a common
ﬁnding during angiogenesis but may also be observed as perivascular edema due to plasma
exudation during inﬂammation. Such inﬂammatory effects may be exerted by activation of
G-protein–coupled receptors such as cysteinyl leukotrienes receptors, which mediate the
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constrictionofvascularsmoothmusclecells.37 Bytheway,D’Andreaetal38 detectedanin-
creaseincysteinylleukotrienesreceptorsgeneexpressiononmacrophagesinperiprosthetic
capsular tissue of patients affected by capsular contracture.39
Summarizing,themodelusedforthecurrentstudyofferedadirectinvivovisualization
of microcirculation and assessment of microvascular and inﬂammatory situation within
peri-implant tissue.
Theresultspresentedindicatethatplasma-mediatedcollagencoatingmaybeapromis-
ing strategy to increase vascularity around implants thus enhancing the biocompatibility
and the versatility of silicone implant material.
Certainly, the ﬁndings made over a period of 10 days cannot be blindly extrapolated
to a long-term in vivo situation. The intravital results reﬂect just snapshots of a short-
term observation. Nevertheless, the analysis at the implant-tissue interface allowed for
determinationoftheinitialcourseofthehosttissueresponseintermsofearlyinﬂammatory
reaction and angiogenesis.
Thus, the induction of angiogenesis and an increased neovascularization in adjacent
tissue of collagen-coated plasma-treated silicone implant materials may indicate a continu-
ing tissue response. Whether the plasma-mediated collagen coating will permit prolonged
inhibition of an avascular capsule formation is unknown. The fact that the neovasculariza-
tion of the tissue in close proximity to treated implants increased and the microcirculation
remained stable throughout the experiment raises the promise of a reduced risk for capsular
ﬁbrosis. Further long-term studies are needed to conﬁrm this assumption.
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